Your browser doesn't support javascript.
loading
Hepatic Dystrophic Calcification Secondary to Transarterial Chemoembolization: Case Report and Review of Literature.
Kumar, Vikash; Shah, Mili; Gala, Dhir; Singh, Manmeet K; Jeanty, Herby; Thomas, Reeny; Forlemu, Arnold N; Gayam, Vijay Reddy; Etienne, Denzil.
  • Kumar V; Internal Medicine, The Brooklyn Hospital Center, New York, USA.
  • Shah M; Internal Medicine, American University of the Caribbean School of Medicine, Sint Maarten, SXM.
  • Gala D; Internal Medicine, American University of the Caribbean School of Medicine, Sint Maarten, SXM.
  • Singh MK; Internal Medicine, American University of the Caribbean School of Medicine, Sint Maarten, SXM.
  • Jeanty H; Internal Medicine, The Brooklyn Hospital Center, New York, USA.
  • Thomas R; Internal Medicine, St George's University, Grenada, GRD.
  • Forlemu AN; Gastroenterology and Hepatology, The Brooklyn Hospital Center, New York, USA.
  • Gayam VR; Gastroenterology and Hepatology, The Brooklyn Hospital Center, New York, USA.
  • Etienne D; Gastroenterology and Hepatology, The Brooklyn Hospital Center, New York, USA.
Cureus ; 15(3): e35765, 2023 Mar.
Article en En | MEDLINE | ID: mdl-37020485
ABSTRACT
Hepatocellular carcinoma (HCC) is a common malignancy usually treated with surgery. Patients who are not suitable for surgery undergo transarterial chemoembolization (TACE) which involves injecting anti-cancer drugs and embolizing agents into the hepatic artery. Although it is a relatively safe procedure with minor side effects, TACE can rarely cause dystrophic calcification in the liver. We report a case of a 58-year-old female who presented with right-sided chest pain. The patient had been previously treated for HCC with a TACE procedure. A chest x-ray revealed hepatic calcification which was likely secondary to the prior TACE. This case study emphasizes the significance of considering TACE as a potential cause of hepatic dystrophic calcification.
Palabras clave